Volume 71, Issue 2 , Pages 86-91, February 2008
Second Primary Malignancies in Squamous Cell Carcinomas of the Tongue and Larynx: An Analysis of Incidence, Pattern, and Outcome
Article Outline
Background
Head and neck cancer patients have a higher risk of developing a second primary malignancy (SPM) than the general population. This study was conducted to identify the characteristics of SPM and its impact on survival in patients with squamous cell carcinoma of the tongue (TSCC) and larynx (LSCC).
Methods
A retrospective study was conducted of 538 patients who were treated by surgery primarily for TSCC (n = 146) and LSCC (n = 392) from 1990 to 2000. The incidence, site, and overall survival of SPMs were evaluated.
Results
Seventy-seven patients developed SPM during the follow-up period (median, 73 months), including 18 (12%) with TSCC and 59 (15%) with LSCC. Fifty-six percent of SPMs of the TSCC group appeared in the oral cavity. Among the SPMs of LSCC patients, 54% developed in the lung (31%) and larynx (24%). The 5-year overall survival after the diagnosis of SPM in the head and neck was 39%, compared to 29% for SPM in other areas (p = 0.010).
Conclusion
SPMs after treatment of TSCC and LSCC are similar in incidence but distinct in pattern. SPMs within the head and neck are associated with a better prognosis than those outside this area.
Key Words: head and neck , laryngeal cancer , second primary tumor , tongue cancer
No full text is available. To read the body of this article, please view the PDF online.
References
- . Second neoplasm in patients with head and neck cancer . Head Neck . 1999;21:204–210
- . Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives . Laryngoscope . 1998;108:250–256
- . Second primary cancers in patients with laryngeal cancer: a population-based study . Int J Radiat Oncol Biol Phys . 2003;56:427–435
- . Second primary cancers in laryngeal cancer patients in Slovenia, 1961-1996 . Eur J Cancer . 2002;38:1254–1260
- . Metachronous second primary tumours in the aerodi-gestive tract in patients with early stage head and neck squamous cell carcinomas . Eur Arch Otorhinolaryngol . 2005;262:905–909
- . Multiple primary malignant tumors: a survey of the literature and a statistical study . Am J Cancer . 1932;16:1358–1414
- Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck . N Engl J Med . 1990;323:795–801
- Second primary tumors in head and neck cancer patients . Acta Otolaryngol . 2002;122:765–778
- . Distant metastases in head and neck cancer patients who achieved loco-regional control . Head Neck . 2000;22:680–686
- Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma . Cancer . 2005;103:2326–2333
- The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial . Cancer Epidemiol Biomarkers Prev . 2001;10:823–829
- . Second primary malignancies in the head and neck cancer patient . Ann Otol Rhinol Laryngol . 1995;104:946–954
- . The molecular biology of mucosal field cancerization of the head and neck . Crit Rev Oral Biol Med . 2003;14:363–369
- . Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions . Head Neck . 2002;24:198–206
- Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC) . Carcinogenesis . 2004;25:269–276
- Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopathologic characteristics and treatment outcomes . Ann Surg Oncol . 2003;10:551–557
- . Current theories for the development of nonsmoking and nondrinking laryngeal carcinoma . Curr Opin Otolaryngol Head Neck Surg . 2003;11:73–77
- . Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids) . Fed Proc . 1976;35:1332–1338
- Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients . J Natl Cancer Inst . 2006;98:441–450
- . Lung cancer after head and neck cancer: role of chest radiography . Laryngoscope . 2000;110:2033–2036
PII: S1726-4901(08)70080-7
doi:10.1016/S1726-4901(08)70080-7
© 2008 Elsevier. Published by Elsevier Inc. All rights reserved.
Volume 71, Issue 2 , Pages 86-91, February 2008
